The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
2,637
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
30-day point prevalence abstinence
No smoking in the past 30 days, as reported 12 month post treatment.
Time frame: 12 month post randomization
7-day, 24-hour, and 30-day point prevalence quit rates
12 months: 24-hour and 7-day point prevalence quit rates. 3 and 6 months: 24-hour, 7-day, and 30-day point prevalence quit rates. Across 3, 6, and 12 month timepoints, the repeated 30-day point prevalence abstinence.
Time frame: 3 months, 6 months, and 12 months post treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.